Company / Financials
PANACEA LIFE SCIENCES HOLDINGS, INC. Financials
FY2014-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$2.4M
FY2023 · +46.6% YoY
Net Income
-$8.0M
FY2023 · +12.3% YoY
Profit Margin
-336.1%
FY2023 · net income / revenue
ROE
-
FY2023 · return on equity
Total Assets
$18.0M
FY2023
Total Debt
-
FY2023
Equity
-$8.3M
FY2023
ROA
-44.6%
FY2023 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$2.4M+46.6% YoYNet Income HistoryProfit after all expenses and taxes-$8.0M+12.3% YoYGross Profit HistoryRevenue minus cost of goods sold$1.1M+183.0% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$1.3M+2.6% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$5.5M+1.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$1.5M+33.2% YoYR&D Expense HistoryResearch and development spending-Interest Expense HistoryCost of borrowing and debt obligations$1.6M-24.0% YoYIncome Tax HistoryTotal income tax expense-EPS (Basic) HistoryBasic earnings per share-$0.48+22.6% YoY